Morphometric assessments, such as muscle density and body fat distribution, have emerged as strong predictors of cardiovascular risk and postoperative morbidity and mortality. To date, no study has examined morphometric mortality risk prediction among kidney transplant (KT) candidates. KT candidates, waitlisted 2008KT candidates, waitlisted -2009 identified (n=96) and followed to the earliest of transplant, death, or administrative end of study. Morphometric measures, including abdominal adipose tissue, paraspinous and psoas muscle composition, and aortic calcification, were measured from CTs. Risk of waitlist mortality was examined using Cox proportional hazard regression. 
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| INTRODUCTION
There is a large unmet need for donor kidneys with over 100 000 patients currently waiting for a deceased donor kidney transplant, yet each year only 11 000 receive a transplant.
1 With annual death rates among waitlist registrants approaching 15%, many die before receiving a kidney transplant.
2
Current kidney transplant selection practices involve a series of evaluations intended to assess perioperative morbidity and mortality, particularly cardiovascular risk, such that allocation of a scarce resource is optimized. 3, 4 However, these assessments are costly and often imprecise, as waitlist mortality remains high in large part due to cardiovascular events. Identification of alternative methodologies for predicting morbidity and mortality among waitlisted ESRD patients is a priority. In fact, a 2012 US consensus conference convened to evaluate "Transplant Program Quality and Surveillance," including a review of the limitations of existing data on pretransplant metrics and an evaluation of the needs for more accurate predictive tools for waitlist mortality. The conference concluded that more data on waiting list mortality risk and outcomes should be provided. 5 Only 51% of dialysis patients are still alive 3 years after initiation of treatment for end-stage renal disease (ESRD), illustrating the extreme vulnerability of these patients compared to the general population. 6 Although comorbidity and disability are associated with mortality and hospitalization in ESRD, [6] [7] [8] [9] [10] [11] 16 However, the test was associated with low sensitivity (70%) and specificity (69%), and is not routinely performed as part of the kidney transplant evaluation process. 16 Moreover, while novel, these additional metrics, such as cTnT, identified to date require additional testing, cost, and time, and, as such, may not be practical additions to an already expensive and intense kidney transplantation evaluation process.
Morphometric assessments, such as muscle density and visceral fat volume, have emerged as strong predictors of cardiovascular risk and postoperative morbidity and mortality. [18] [19] [20] [21] Morphometric analyses do not require any additional testing, as these measurements are made using preoperative computed tomography (CT) imaging routinely obtained as part of many transplant center selection practices.
To date, no study has examined morphometric risk prediction and mortality among waitlisted ESRD patients. 22, 23 Given the significant knowledge gap regarding risk prediction among kidney waitlist candidates, we leveraged the second largest kidney transplant waiting list in USA and examined the relationship between morphometric measures and waitlist mortality.
| PATIENTS AND METHODS

| Data source
The study used data from our center's transplant registry, which includes data on all kidney waitlist candidates and transplant recipients at our center. The use of these data and a waiver of informed consent were approved by our Institutional Review Board (Protocol Number: x140509006).
| Study population
Adult kidney transplant candidates listed at UAB between 2008 and 2009 with CT imaging of their abdomen and pelvis performed at the time of evaluation were identified (n=320). Candidates whose CT scan quality permitted complete analysis of all morphometric measurements of interest were included (n=96).
| Traditional risk factors
Patient characteristics traditionally associated with cardiovascular mortality were abstracted from the medical record. These traditional measures included age, race, BMI, length of time spent on dialysis, comorbidities such as diabetes, hypertension, and peripheral vascular disease (PVD), social history, and family history of diabetes, hypertension, and chronic kidney disease (CKD)/ESRD. These factors were abstracted from the record on or closest to the date of listing for transplant. 
| Morphometric measures
| Exploratory data analyses
Characteristics were compared by candidate status-death on the waiting list, transplantation, still waiting. Continuous variables were analyzed using Kruskal-Wallis tests, and categorical variables were examined using chi-square tests of independence.
| Outcome ascertainment
The primary outcome was waitlist mortality. Death dates were 
| Survival analyses
Risk of mortality was examined using multivariable Cox proportional hazard regression. Factors found to be significant on univariate analyses, as well as traditional factors known to be associated with cardiovascular mortality, were considered for model development, with the most parsimonious model chosen by minimizing Akaike's information criterion. Analysis considering transplantation as a competing risk was performed using the Fine and Gray method, and inferences were confirmed (Table S1 ). 28 All analyses were performed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA), Stata version 14 (StataCorp, College
Station, TX, USA), and R version 3.2.5 (R Foundation for Statistical
Computing, Vienna, Austria).
| Model discrimination and calibration
The discriminative ability of the standard Cox model was calculated with Harrell's C-index. To assess calibration of the model, we stratified patients by quantile of risk and compared observed and expected waitlist mortality using the Groennesby and Borgan score test. 29, 30 To assess improvements in discrimination between a model contain- 
| Sensitivity analyses
Additional models were built, including models chosen by backward, forward, and stepwise selection and factors significant at an alpha of <0.10 on univariate analyses. Active status on the waitlist was considered, and results were found to be similar to the competing risk model (Table S2) . Models considering other traditional risk factors were generated (Table S3) . Inferences of the reported parsimonious model were confirmed.
| RESULTS
| Kidney transplant candidate characteristics
The cohort at the time of being added to the waitlist had a median age of 50.7 years (IQR: 40.1-58.0), 57% were male, 52% were African American, 52% were blood group O, and the median time spent on dialysis prior to evaluation for transplant was 0.63 years (interquartile range [IQR]: 0.0-2.30). Comorbid conditions were common, including diabetes 44%, hypertension 90%, coronary artery disease 39%, and PVD 4%. Nine percent of the cohort was infected with hepatitis C, and 22% had a history of prior transplant. After a median of 3.9 years of follow-up (IQR: 1.3-6.1), 39 patients died while waiting, 26 patients were transplanted (13 received deceased donor transplants, and 13 living donor transplants), and 31 were still awaiting kidney transplant.
Among those transplanted, median waiting time was 0.9 years (IQR:
0.3-3.1).
| Waitlist mortality
We explored traditional risk factors known to be associated with increased risk for cardiovascular morbidity and mortality ( Table 1 ).
Candidates that died while waiting were older than those who achieved transplant or remained on the waitlist (54. We also explored previously reported morphometric measures associated with increased risk for cardiovascular morbidity and mortality (Table 2) . Total abdominal, visceral, and subcutaneous fat volumes showed no association with waitlist mortality although abdominal fat attenuation was slightly higher in those that died on the WL. Skeletal muscle composition of the paraspinous and psoas muscles was strongly associated with waitlist mortality in unadjusted analyses. Lean and total muscle attenuation were each lower in those who died than either those transplanted or still awaiting transplant for both the paraspinous and psoas muscles. These lower attenuations were consistent with higher fat volume to total muscle volume ratios in those who died compared to those who were transplanted or were still alive awaiting transplant. Abdominal aortoiliac calcified plaque prevalence and calcified plaque burden (higher Agatston scores) were higher in those who died awaiting transplant. there was an associated 3% increased risk of waitlist mortality (aHR:
1.03, 95% CI: 1.00-1.06, P=.02), and for each HU increase in paraspinous muscle lean volume, there was an associated 2% decreased risk of death (aHR: 0.98, 95% CI: 0.96-0.99, P=.03).
When the discriminative ability of a model containing only the traditional risk factors was compared to that including both the traditional and the morphometric factors, the model including both was shown to have an NRI of 0.555 (95% CI: 0.31-0.75, P<.001), indicating that the predictive ability of the model for waitlist mortality was improved significantly by including radiologic measures.
| DISCUSSION
In this single-center study of kidney transplant waitlist candidates, we found that morphometric measures of lean abdominal mass as measured by CT imaging were independently associated with waitlist mortality. Specifically, higher psoas muscle attenuation or greater lean muscle mass was protective, such that for each HU increase in attenuation, there was a 7% decrease in risk of death. Additionally, greater volume of the lean paraspinous muscle was associated with a 2% lower risk of death, and higher fat attenuation was associated with a 3% increased risk. These findings were independent of factors traditionally known to be associated with increased risk of waitlist mortality, including candidate age and length of time on dialysis, and suggest that morphometric measures of sarcopenia using radiologic imaging may improve kidney waitlist mortality risk prediction and candidate selection.
Sarcopenia describes the lean mass reduction typically seen with aging and is a component of frailty. 33, 34 It is estimated that 42% of dialysis patients meet criteria for frailty, and among those dialysis patients older than 50 years, the incidence is greater than 50%. 10, 35 Frailty in the dialysis population is associated with a 2.6-fold increased risk of mortality and a 1.43-fold increased risk of hospitalization independent of age, comorbidity, or disability. 35, 36 Sarcopenia increases progressively along with loss of renal function in chronic kidney disease 37 and represents a significant component of the increased mortality risk seen among frail dialysis patients. In particular, morphometric measures Inferences based on the results of our study must take into account several limitations specific to single-center retrospective studies. Alternative provider-based measures of sarcopenia, such as gait, grip strength, mid-arm muscle circumference, or triceps skinfold thickness, were not measured as a part of our center's evaluation process. As a result, a direct comparison of the predictive ability of radiographic and provider-based measures of sarcopenia could not be studied. Additionally, this study was designed as a pilot project. Due to resource constraints and variability of CT image quality, we were only able to obtain complete morphometric data on 96 patients, thus introducing the possibility for selection bias. Larger studies will be necessary to confirm our findings.
To date, this is the first study to examine the association between radiographic morphometric measures of sarcopenia and kidney waitlist mortality. Our findings suggest that muscle size and density are independently associated with kidney waitlist mortality and that higher lean muscle mass may be protective. Radiologic measures of sarcopenia, such as psoas muscle attenuation and paraspinous lean volume, may help to improve waitlist mortality risk adjustment and prediction and candidate informed consent.
